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ARTICLE
Spatially and cell-type resolved quantitative
proteomic atlas of healthy human skin
Beatrice Dyring-Andersen1,2,3,4, Marianne Bengtson Løvendorf5, Fabian Coscia1, Alberto Santos1,
Line Bruun Pilgaard Møller1, Ana R. Colaço1, Lili Niu1, Michael Bzorek6, Sophia Doll7, Jørgen Lock Andersen8,
Rachael A. Clark2, Lone Skov 4, Marcel B. M. Teunissen 9 & Matthias Mann 1,7✉
Human skin provides both physical integrity and immunological protection from the external
environment using functionally distinct layers, cell types and extracellular matrix. Despite its
central role in human health and disease, the constituent proteins of skin have not been
systematically characterized. Here, we combine advanced tissue dissection methods, flow
cytometry and state-of-the-art proteomics to describe a spatially-resolved quantitative pro-
teomic atlas of human skin. We quantify 10,701 proteins as a function of their spatial location
and cellular origin. The resulting protein atlas and our initial data analyses demonstrate the
value of proteomics for understanding cell-type diversity within the skin. We describe the
quantitative distribution of structural proteins, known and previously undescribed proteins
specific to cellular subsets and those with specialized immunological functions such as
cytokines and chemokines. We anticipate that this proteomic atlas of human skin will become
an essential community resource for basic and translational research (https://skin.science/).
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Human skin serves as the interface between the body andthe surrounding environment, and, as such, it providesessential functions such as sensing and immunological
protection. The skin also provides physical protection against
injury and assists in the control of body temperature and our
perception of the surrounding environment through sensory
nerves. Accordingly, the skin is a complex organ comprising
multiple tissue layers and diverse cell types, including melano-
cytes, endothelial cells, keratinocytes, fibroblasts, and skin-
associated immune cells. It also contains a high density of
extracellular matrix (ECM) that contributes to its tensile strength
and flexibility. More than a century of research on the skin and its
structure has provided an increasingly granular view of this
complex organ, including its micro-anatomy and the multitude of
immune and other cells it contains1–5. Recently, transcriptomic
profiling studies of skin, including analyses at the single-cell level,
have mapped the gene expression landscape of skin-associated
cells and revealed the presence of skin-specific genes6–8. This
suggests that the skin and its component cell types likely employ
unique proteomes to facilitate the unique structural, homeostatic,
and immune functions of skin.
Despite its importance, there have been no prior comprehen-
sive and quantitative studies of the molecular composition of
healthy human skin at the protein level. Previous studies have
identified a small fraction of the expressed proteome, likely
because of difficulties in separating and homogenizing tissue and
the dominance of structural proteins such as keratin (KRT)9–11.
Recent technological advances in the field of mass spectrometry
(MS)-based proteomics have dramatically improved the sensi-
tivity, throughput, completeness and quantitative accuracy of this
technique12–15. MS-based proteomics have now become a sensi-
tive and accurate method for large-scale, unbiased proteomic
analyses that enable characterization of nearly complete pro-
teomes16–18.
Here, we combine MS-based proteomics with an advanced
sampling strategy that accounts for the cellular complexity of the
skin. This approach yields a highly resolved quantitative pro-
teomic atlas of the different layers and cell types in healthy
human skin, allowing us to measure and map the quantitative
distribution of functional and structural proteins. As a first
example of how this atlas can be used, we analyze immune cell
types and proteins with known immunologic functions, yielding a
spatial and cellular map of cytokine production. This proteomic
atlas provides a comprehensive characterization of the quantita-
tive distribution and relationships of proteins in human skin. It
therefore represents a valuable resource for future systematic
studies of the biology and pathology of human skin.
Results
An in-depth quantitative proteomic atlas of human skin. To
create a layer and cell-type resolved proteomic atlas of the human
skin, we used healthy skin from plastic surgeries (see “Methods”).
Initially, we removed stratum corneum with tape stripping;
however, we found that this method did not allow us to sample
the inner epidermis. Instead, we dissected inner and outer epi-
dermis by curettage and subsequently used punch biopsies for
dermis and subcutis (Fig. 1a). This procedure cleanly divided the
layers as judged by histology (Supplementary Fig. 1a–c). In
addition, we established primary cell cultures of keratinocytes and
fibroblasts from the same skin donors (see “Methods”)19. Finally,
we isolated immune cells, melanocytes and endothelial cells by
enzymatic digestion followed by FACS (Supplementary Fig. 2).
Together, these samples comprise the complete depth of the skin
tissue and its major cell types. We derived the tissue material
from six individuals, whereas immune cells were obtained from
up to 21 donors, resulting in a total of more than 60 proteome
samples (see Methods). From each of them, we extracted proteins
through a combination of tissue homogenization, heating and
ultrasonication, followed by overnight tryptic digestion.
To construct an inventory of skin proteins that’s as
comprehensive as possible, we pooled all samples across donors
and separated them into eight or 16 fractions by high-pH
reversed-phase fractionation20. All samples were measured on a
quadrupole orbitrap mass spectrometer in 100min data-
dependent acquisition mode (DDA) (Fig. 1a–b, Q Exactive HF-
X, Methods). The resulting proteome library comprised 173,228
sequence-unique peptides accounting for 10,701 proteins in total
with a median protein sequence coverage of 39.4% (Supplemen-
tary Data 1). The proteins that were quantified in the present
study spanned more than six orders of magnitude. Given the
challenging nature of this tissue, this is an unprecedented depth
of coverage, providing an excellent basis to study skin function
and composition on a global proteomic level.
This proteome library served as a deep spectral library for all
data-independent acquisition (DIA) runs, which we performed
separately on the three to six donor replicates for each skin layer
and cell type, resulting in a total of 60 DIA proteome
measurements (Fig. 1c). This was particularly valuable for the
immune cell types, where sample amounts were very limited. In
the fractionated proteomes, we identified 8987 proteins in the
outer epidermis (stratum corneum) and 9140 proteins in the
inner epidermis (comprising cell layers down to basal mem-
brane). In the dermis and in the subcutis, we identified a
somewhat lower number of proteins (8340 and 6334 proteins,
respectively) due to the high proportion of extracellular matrix
(ECM) and correspondingly fewer cells (Fig. 1d). We used the
peripheral blood mononuclear cell (PBMC) proteome as the
benchmark library for the analysis of skin-associated epidermal
and dermal T cells (Fig. 1d).
To visualize proteomic similarities and differences across skin
layers and cell types, we employed principal component analysis
(PCA) (Fig. 1e). Skin layers and cells segregated by the first and
second component with 24.0% and 11.0% of the total data
variation, respectively. The separation between skin layers and
skin-derived immune cells was partially driven by proteins of the
ECM, including collagens and collagen associated proteins of the
skin, such as dermatopontin, prolargin, decorin, and lumican.
Overall, we found that the majority of proteins (6025; 56.3%)
were expressed in all four layers, whereas 3631 (33.9%) were
expressed in some, but not all layers, and only few (569; 5.3%)
were exclusive for one specific layer (Fig. 2a). These findings are
in line with previous work on other tissues showing that the
majority of expressed proteins are shared across multiple tissue
types while protein abundance varies substantially21–23.
The spatial gradient of the skin proteome. A prominent feature
of the skin is its layered composition, with each layer having a
distinct functional role. Previous analyses have documented dif-
ferences that suggested the existence of the molecular spatial
gradients of structural and immune proteins across skin
layers1,24–27. To capture this at the proteomic level, we next
analyzed our DDA dataset for the structural and immunological
composition of the skin layers as a function of the spatial
dimension. Below, we summarize several key observations.
First, our analysis of epidermis identified and quantified 47
keratins (KRTs), which represents all known skin KRTs24,28. We
found that KRTs 1, 5, 10, 14, and 6A were most abundant in
epidermis, comprising 87% of KRTs in the outer epidermis and
93% in the inner epidermis (Fig. 2b, e, g, I, Supplementary
Data 2). They make up 15% of the total inner epidermal
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Fig. 1 In-depth MS-based proteomic analysis of skin layers and its cellular subsets. a Workflow for measuring the skin proteome including skin layers,
cultivated keratinocytes, and fibroblasts and FACS-sorted melanocytes, endothelial cells, and immune cells. b High-resolution MS analyses of fractionated,
pooled samples in data-dependent acquisition mode (DDA) and subsequent (c) single-run analyses of three to six biological replicates in data-independent
(DIA) acquisition mode. d Number of protein groups for each major cell subset and skin layers based on pooled samples (one independent experiment) for
cell subsets and skin layers, respectively examined over one independent experiment (CD1A+dendritic cells (N= 3), CD14+ dendritic cells (N= 3),
macrophages (N= 4), mast cells (N= 6), fibroblast (N= 5), keratinocytes (N= 5), endothelial cells (N= 4), melanocytes (N= 5), skin layers (N= 5).
A total of 10,701 protein were identified. e Principal component analysis (PCA) of all proteomes from skin layers, primary cells and immune cell types.
Color code from panel (d). The fractionated proteome of PBMC (green dot) was included as library for skin-associated T cells. Component 1 and 2 account
for 24 and 11% of the total data variation, respectively.
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proteome (Fig. 2c). KRT 16 and 17 are ascribed specific roles as
“alarmins” of the immune system29, and supporting this notion,
KRT 16 made up 6.7% of total keratins in the outer epidermis
but only 0.1% of inner epidermis (2.6% and 0.3% for KRT 17).
Moreover, there were clear patterns in abundance of
transglutaminases, enzymes that catalyze crosslinking the pro-
teins of cornified cell envelope to render the outer skin
mechanically stable30. We observed that transglutaminase 1 and
3 were by far the most abundant in epidermis (0.02%, 0.01%
of protein mass, respectively), whereas forms 5 and 2 were
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comparatively ten times less abundant (Fig. 2b). We found
distinct gradients in their expression suggesting that this crucial
function happens mainly in the epidermis (Fig. 2b, Supplemen-
tary Data 2). In another example, our data show that the
desmosomal proteins desmoglein, desmocollins, plakoglobin,
desmoplakin, envoplakin, periplakin and plakophilin alone
account for approximately 1.8% of protein mass of the inner
epidermis (Fig. 2b). This is in agreement with the critical role of
desmosomes in forming intercellular junctions that link the
keratinocytes to each other and to the intracellular filament (IF)
network, thus resulting in adhesive protein network that
functions to withstand mechanical stress in the basal layers of
epidermis31.
Moving towards deeper skin layers, we found that glycopro-
teins such as elastin and laminins were the most abundant in the
dermis (Fig. 2b, c), with elastin accounting for 20% of the
annotated glycoproteins in the dermis. Of the collagens, we found
all 16 that have been described in interfollicular skin before, with
collagen I, III, IV, and VI alone comprising 96% of their total
mass in the dermis (Fig. 2b, f, h, j, Supplementary Data 2).
Interestingly, we quantified low amounts of collagen XXI
(COLXXI), a family member that has so far only been described
in extracellular matrix in the heart, stomach, kidney, placenta and
smooth muscle32. Together collagens make up 10% of total
protein mass in the dermis (Fig. 2c). Elastins, laminins and
collagens are thought to provide structural scaffolding and
elasticity to the dermis; our quantitative proteomic data confirms
that these proteins are well placed to carry out these functions. In
addition to its structural role, the skin acts as both an active and
passive immunologic barrier. Therefore, we next analyzed the
spatial gradient of proteins with immunological roles. The
members of the S100 family of Ca2+- and Zn2+ binding proteins
were by far the most abundant, and their members had very
distinct spatial profiles. Whereas S100A7, S100A8, and S100A9
were more abundant in outer epidermis, S100A14/16 were more
abundant in epidermis and keratinocytes, and S100A6 in dermis
(Fig. 2b, d, Supplementary Data 2). These observations agree with
the proposed roles of S100 proteins in pro-inflammatory and
antimicrobial activities and keratinocyte differentiation, and the
previously reported differences in their expression profiles26.
Our proteomic data also demonstrated the presence of a wide
arsenal of immunologically active proteins, including chemokines
(CXCL12/14), antimicrobial peptides (defensin β1/β2), matrix
metalloproteinases (MMP2/3/9) and cytokines. We next analyzed
expression of the members of the interleukin (IL) 1 cytokine
family; interleukins play critical roles in defending against
infection and contribute to inflammatory skin diseases33,34.
Interleukins are extremely difficult to identify with proteomic
methods because of their low abundance, especially in the absence
of inflammation. Remarkably, we identified all members of the
IL-1 family and quantified their spatial and cellular expression
patterns, including IL-18, IL-37, IL-38 and IL-36γ, which were
mainly detected in the epidermal layers (Fig. 3). Unexpectedly,
IL-36α, a poorly described family member, was restricted to the
subcutis, and at least nine fold more abundant than other IL-1
family members in any skin compartment (Fig. 3f). Low levels of
the recently described cytokine IL-33 were localized to the dermis,
and further localized to endothelial cells, as reported in the
literature (Fig. 3g, h)35. IL-1β was readily quantified in isolated
dendritic cells and macrophages. We did not detect IL-1β protein
in healthy skin by immunohistochemistry, but IL-1β was
produced by macrophages and dendritic cells from inflamed skin
(Fig. 3i, Supplementary Fig. 3). Lastly, medically targeted
cytokines known to drive inflammatory skin diseases such as
psoriasis (IL-17, IL-22, and IL-23) and atopic dermatitis (IL-4, IL-
5, IL-13) were not identified in healthy skin. Taken together, these
studies represent a detailed quantitative proteomic analyses of
immunologically active proteins within the distinct structural
compartments and cell types in human skin.
Proteomic atlas of cultivated fibroblasts and keratinocytes.
Following our proteomic characterization of skin layers by data-
dependent acquisition, we next analyzed the constituent cell types
in skin. Keratinocytes and fibroblasts are by far the most frequent
component cell types, followed by the endothelial cells that line
blood and lymphatic vessels, pigment-producing melanocytes and
then the cellular subsets of the resident innate and adaptive
immune systems. We chose DIA as the best method to compare
proteomes between these diverse cell types. To minimally disturb
the proteomes, we isolated and FACS-sorted cells directly from
single-cell suspensions of digested skin. However, this was not
appropriate for fibroblasts and keratinocytes because both lack
distinct and stable surface markers for sorting. We therefore used
cultured fibroblasts and keratinocytes to characterize the pro-
teome and to identify novel and specific cell type markers.
Endosialin (CD248/TEM1) has previously been reported to be
a intracellularly expressed protein in skin fibroblasts36. We
therefore investigated its MS-based abundance across cell types.
Endosialin was within the top third of the proteome in fibroblasts,
whereas it was hardly detected in any other cell type. Thus, we
used the endosialin abundance profile across cell types as a
reference to identify the top 100 proteins with similar abundance
pattern (Fig. 4a, b, Supplementary Data 3). Some of the proteins
identified using this strategy include SLIT2, FGF2, PRRX1, which
have been mentioned in the context of fibroblast biology37,38,
LOXL4, with a role in collagen crosslinking39, and GREM1,
COL11A1, LRRC15, all differentially associated with cancer-
associated fibroblasts but not quiescent skin fibroblasts40,41
(Fig. 4c, d). The analysis also highlighted the protein C12orf75
that, to the best of our knowledge, has not been characterized in
Fig. 2 Spatial proteomic gradient of human skin. a Unique and overlapping protein groups in outer and inner epidermis, dermis and subcutis skin layers
(UpSet plot) One independent experiment of pooled samples (N= 1) from five donors for each layer). b Relative expression levels of important structural
and immunological proteins across skin layers and in primary keratinocytes and fibroblasts. Clustering is based on the log2 expression level of the proteins
in skin layers (DDA). c Protein mass percentage of keratins, collagens, glycoproteins and secreted proteins across skin layers. Percentage was calculated by
dividing the summed iBAQ intensities of the proteins of interest by all summed iBAQ intensities of all proteins (see Methods). d Expression profiles of the
S100A family members of proteins across skin layers, illustrating their layer-specific, functional abundance. e, f Estimated protein abundance vs protein
rank highlighting keratin 1 (KRT1), keratin 14 (KRT14), and collagen III (COL3A1) (upper panels) and (g, h) immunohistochemical stainings (KRT1, brown,
KRT14, red, COL3A1, brown) (lower panels), scale bar: 50 µm. KRT1 is the protein with the 7th highest estimated abundance in outer epidermis, whereas
KRT14 is the 6th most abundant. COL3A1 is the 19th most abundant protein in dermis, which is also reflected in the staining. i Estimated abundance of
KRT1 and (j) COL3A1 across libraries based on pooled samples of skin layers and skin-derived cells examined over one independent experiment from
pooled samples (N= number of pooled donor samples). (CD1A+dendritic cells (N= 3), CD14+ dendritic cells (N= 3), MΦ; macrophages (N= 4), MC;
mast cells (N= 6), Fib; fibroblast (N= 5), KC; keratinocytes (N= 5), EC; endothelial cells (N= 4), Mel; melanocytes (N= 5), skin layers (Outer Epi, Inner
Epi, Dermis, Subcutis) (N= 5). Source data are provided as a Source Data file.
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fibroblasts, but has been found overexpressed in colon cancer
(Fig. 4e)42.
A similar analysis on the primary keratinocytes revealed that
the known marker kallikrein 10 was in the top half of the
quantified keratinocytes proteome, with negligible expression
elsewhere (Fig. 4f, Supplementary Data 4).
The top 100 proteins that best correlated with keratinocytes
included cell-to-cell adhesion proteins (cornifelin, plakophilin
3, TNS4, DSG3, LAD1), proteins associated with epithelial cell
transformation and differentiation (FAM83B, ZNF185) and
KLK5, an additional keratinocyte-specific kallikrein6,43–48. Our
analysis also uncovered a number of proteins that have not
been functionally characterized in the context of keratinocyte
biology, including TMEM40, FGFBP, CRCT1, EGFLAM,
Anxa8AL1, and NT5DC3 (Fig. 4g–j). Conversely, a number
of functionally important proteins that have been documented
as expressed by keratinocytes during the differentiation process
in vivo were not identified in monolayer keratinocyte cultures.
Among these are a number of keratins, late cornified
envelop proteins such as LCE1E, LCE1F, and LCE6A and
loricrin. As we had readily identified almost all of these
proteins in the relevant skin layers, these differences likely
exemplify the biological differences between cultured and
in vivo keratinocytes.
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in the skin. b, c Estimated intensity of the IL-1 family members IL-36γ and IL-37 throughout the skin. IL-36γ is primarily found to be expressed in the outer
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brown), scale bar: 50 µm. e, f Estimated intensity of the IL-1 family members IL-18 and IL-36α throughout the skin. IL-18 is mainly found in the inner- and
outer epidermis whereas IL-36α is found in subcutis. g Immunohistochemical staining of IL-33 expression on healthy skin obtained from the Human Protein
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EC; endothelial cells (N= 4; h, i), Mel; melanocytes (N= 5; h, i). Source data are provided as a Source Data file.
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The proteomes of cellular subsets reveal unexplored proteins.
Comprehensive proteomic analyses of the cellular subsets of
human skin has been hampered by the technical challenges of
obtaining the number of cells needed for these analyses. Conse-
quently, the majority of studies published to date relied on either
immunohistochemical analyses or on cultured cells. We prepared
freshly isolated single-cell suspensions from the skin of three to
six healthy donors and used multi-parameter flow-cytometry
based sorting to isolate purified cell types. We prepared 34 sam-
ples that were analyzed by single-shot DIA MS-based proteomics
(Fig. 5) (see “Methods”). In addition to the endothelial cells and
melanocytes mentioned above, we analyzed mast cells, macro-
phages and dendritic cells of the innate immune system and
epidermal and dermal T cells of the adaptive arm of the immune
system. We used the deep proteomes of cellular subsets including
endothelial cells, melanocytes, dendritic cells, mast cells, macro-
phages and PBMCs as matching libraries for DIA (constituting
between 8726 and 10,337 proteins, Fig. 1d). To verify the high
purity of the FACS-sorted cell types, we employed the MS-signals
of the characteristic markers of all cellular subsets (Supplemen-
tary Fig. 1d–m). For each of the FACS-sorted cell types, we
covered a quantitative proteome of between 5100 and 6700
proteins (Fig. 5a). We visualized commonalities and differences
between cellular subsets with a PCA plot, in which we also
included the cultivated subsets (Fig. 5b).
As expected, cultured subsets clustered away from freshly
isolated subsets; proteins associated with cornification and
keratinization driving the separation of keratinocytes and
functionally important proteins such as CPA3, CMA1,
and CDH5 contributing to the separation of immune cells.
Within the FACS-sorted cell types, melanocytes and endothelial
cells clustered closely together and apart from immune cells,
despite having very distinct roles in the skin. The two different T-
cell populations were also substantially separated (Fig. 5d).
Standard ANOVA analysis between cellular proteomes of the
FACS-sorted cells revealed large differences in the expression
profiles of these populations (6713 of a total of 8212 proteins,
FDR < 0.05, Supplementary Data 5). Gene ontology (GO)
enrichment analysis in the first instance highlighted differences
between the melanocytes and endothelial cells vs. immunological
cell types. For the melanocytes, we observed enrichment of
proteins involved in melanin biosynthetic process (KIT, MLANA,
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TYRP1, DCT, DDT, TYR, and MYO5A) as well as phagosome
acidification-associated proteins responsible for dispersing mel-
anin to neighboring keratinocytes49. We next ran a posthoc
pairwise t-test analysis across all cell types to reveal proteins that
were significantly different in at least two cell types (FDR < 0.01;
fold-change>2). This stringent approach revealed a set of
1272 such proteins, including proteins involved in Toll-like
receptor (TLR) signaling pathway in macrophages and proteins
involved in antigen processing in dendritic cells. Hierarchical
clustering of these proteins based on abundance levels across
cell types yielded a heatmap with clearly distinct protein
clusters (Fig. 5c; Supplementary Data 6). Within each of these
clusters, in addition to proteins with the established functions
in the respective cell types, we observed proteins without a
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Fig. 5 In-depth MS-based proteomic analysis of skin-associated cellular subsets. a Single-run analyses of DC; CD1A+dendritic cells (N= 3), MΦ;
macrophages (N= 4), MC; mast cells (N= 6), ET; epidermal T cells (N= 6), DT; dermal T cells (N= 6), EC; endothelial cells (N= 4), Mel; melanocytes
(N= 5), Fib; fibroblasts (N= 5) and KC; keratinocytes (N= 5) using data-independent (DIA) acquisition. Data are presented as mean±SEM. N represents
number of biologically independent samples. The number of quantified protein groups for each major cell lineage is roughly similar. Source data are
provided as a Source Data file. b Principal component analysis (PCA) of all proteomes from cellular subsets. Color code from panel (a). The PCA separates
cultivated fibroblast and keratinocytes from FACS-sorted endothelial cells (EC) and melanocytes (Mel) as well as from the immune cells, as indicated by
enclosing ovals. c Heatmap of protein abundances of 1272 differentially expressed proteins (ANOVA, FDR < 0.01, FCH > 2) after unsupervised hierarchical
clustering. d Differentially expressed proteins in epidermal T cells vs. dermal T cells (volcano plot, FDR < 0.05, FCH > 2).
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well-established role in the given cell type. This substantial group
contained 39 kinases and 16 ubiquitin protein ligases whose
function in skin biology has not been established (Supplementary
Data 7 and 8).
Next, we performed a profile analysis on the FACS-sorted cells.
For each cell type, we chose previously characterized proteins
with cell type restricted expression profiles as references and
determined the top 100 proteins with the most similar profiles
(Fig. 6). We observed that although expression of reference
proteins was very restricted to the respective cell type, profiles of
the top 100 proteins displayed more variability, indicating that
there is a limited number of proteins with unique expression. This
was particularly the case for mast cells and melanocytes. The
distinct T-cell profile resulted from combining dermal and
epidermal T cell populations (for distinguishing proteins see
below). Together, these characteristic sets that emerged from the
hierarchical clustering and the profile analysis may represent
proteins that are functionally relevant for these skin cell types,
and therefore their future study could reveal novel aspects of their
biology. Below, we highlight some of the interesting observations
that emerged from our initial analysis of characteristic sets for
dendritic cells, macrophages, mast cells, skin T cells, endothelial
cells, and melanocytes.
Dendritic cells act as sentinels by detecting pathogens in the
skin, and serve as a link between the innate and the adaptive arms
of the immune system. These cells have characteristic expression
of C-type lectin receptors that recognize glycan structures on
pathogens and commensals, and CD1a, CD1b, and CD1c
molecules, that present lipid and glycolipid antigens to other
immune cells50. Using CD1c as the reference, we selected 99
proteins with the most similar expression pattern (Fig. 6a, b,
Supplementary Data 9). This characteristic set included, as
expected, CD1b (Fig. 6d), as well as several C-type lectin
receptors (CLEC4A, CLEC5A, CLEC10A), activation marker
(TRAF1), chemokine (CCL22) and chemokine receptor (CCR2),
and immune function (PLD4, SIGLEC9, ALOX15. We also
detected NMES1 (Fig. 6c), a protein recently described to be
specific for dendritic cells and involved in effector functions51,52.
Interestingly, many of the proteins that are specifically enriched
in dendritic cells, for example enzymes such as PDCL3 and
FCHO1 have no known function in the skin and represent strong
candidates for follow up studies.
To define the macrophage “characteristic set” we used the
innate immune sensor CD163 as a reference protein (Fig. 6e, f,
Supplementary Fig. 1, Supplementary Data 10). It included
proteins with known functions in innate immunity (LILRB4,
C1QA-C, C3AR1, CD14, C2, C8A), chemotaxis (CCL18, CCL3),
immune regulatory function (ABC1, VSIG4) and stress response
in the context of tumorigenesis (RNASE2, GPX3), as well as
FOLR2 (Fig. 6h). This set of proteins also included MS4A6A and
TMEM176B, members of the MS4A family, whose founding
member is CD20 (MS4A), a well-characterized B‐cell marker.
Both MS4A6A and TMEM176B have not been functionally
explored but are highly enriched in macrophages (Fig. 6g)53,54.
For analysis of mast cells, we used carboxypeptidase A (CPA3)
as reference (Fig. 6i, j, Supplementary Data 11). The resulting
characteristic set of proteins selectively enriched in mast cells
includes regulators of mast cell activation (RGS13, PIK3R6,
PIK3C2B, RHOG), characteristic proteases (tryptase, chymase
and carboxypeptidase M), proteins involved in innate immunity
(TRIM38, TRIM23) and proteins with unknown function in the
context of mast cell biology (LAT2, SLP3) (Fig. 6k, l).
Skin T cells are dispersed in the skin and mostly prevalent in
the dermis in proximity to blood vessels, hair follicles and eccrine
sweat ducts4. There are different populations of skin T cells, most
prominently dermal and epidermal T cells, which are all defined
by the expression of a T-cell receptor (TCR) that is assembled
from multiple chains. We used the CD3δ chain of TCR to define
characteristic set of both dermal and epidermal T cells (Fig. 6m,
n, Supplementary Data 12). Apart from the other constituents of
the TCR, including CD3γ and CD3ɛ chain, the known surface
receptors CD5 and CD6 were also exclusively expressed by
T cells. Other proteins involved in regulation of TCR stimulation
(SKAP1, SH2D1A, SIT1, FYB1, CARMIL2, LIME1, PTPRCAP),
cytolysis (GZMA, GZMK, CTSW), antiviral activity (APO-
BEC3G), complement activation (C5) and cytokine production
(KAMK4, IKZF3, GBP5) were found to be highly enriched in
T cells. Remarkably, the T-cell profile set also contained many
proteins that are completely uncharacterized or remain to be
functionally characterized with respect to their function in T cells
(PYHIN1, ACAP1, PNPLA7, SEPTIN1) (Fig. 6o, p). We also
observed that epidermal and dermal T cells exhibited clear
differences (Figs. 5b and 6d, Supplementary Data 13), further
supporting the proteomic diversity we observed in distinct skin
layers.
Endothelial cells line the blood and lymphatic vessels of the
skin. These cells act as a semi-selective barrier between the lumen
and the surrounding tissue and regulate trans-endothelial
migration of immune cells. We used cadherin 5 (CDH5), an
adhesion molecule between endothelial cells, as a reference for
defining the characteristic set of endothelial cells (Fig. 6q, r,
Supplementary Data 14). The resulting set included typical
endothelial cell proteins such as leukocyte adhesion molecule
selectin E and P (SELE and SELP, respectively), tight junction
protein claudin 5 (CLDN5), and endomucin (EMCN), a regulator
of VEGF mediated cell migration and growth. The set also
confirmed endothelial cell enrichment of proteins such as
RAPGEF3 and ABCB1, regulators of vascular permeability55
Fig. 6 The proteomes of cellular subsets from the skin reveal subset enriched proteins. Protein expression profiles for the top 100 proteins across cell
types using specific, well-characterized proteins as reference for each subset. a Protein expression profile of DCs using (b) CD1c as a reference (red line in
(a)). Protein expression of selected proteins enriched in DCs (c) NMES1 and (d) CD1b across cell types. e Protein expression profile of MΦ using (f) CD163
as a reference profile (red line in (e)). Protein expression of selected proteins enriched in MΦ (g) MS4A6A and (h) FOLR2 across cell types. i Protein
expression profile of MCs using (j) carboxypeptidase A (CPA3) as a reference profile (red line in (i)) and expression of selected proteins enriched in MCs
(k) LAT2 and (l) SYTL3) across cell types. m Protein expression profile of ETs and DTs using (n) T-cell receptor chain CD3δ as a reference profile (red line
in (m)). Protein expression of selected proteins enriched in ETs and DTs (o) PTPRCAP and (p) SEPTIN1 across cell types. q Protein expression profile of
ECs using (r) adhesion molecule cadherin 5 (CDH5) as a reference profile (red line in (q)) and bar plots illustrating the expression of selected proteins
enriched in ECs (s) DYSF and (t) KANK3 across cell types. u Protein expression profile of melanocytes (Mel) using (v) adhesion molecule melanogenesis
pathway member Melan-A (MELAN-A) as a reference profile (red line in (u)) and bar plots illustrating the expression of selected proteins enriched in
melanocytes (w) MTURN and (x) CRYM) across cell types. All barplots are presented as mean±SEM, (log2). DC; CD1A+dendritic cells (N= 3), MΦ;
macrophages (N= 4), MC; mast cells (N= 6), DT; dermal T cells (N= 6), ET; epidermal T cells (N= 6), EC; endothelial cells (N= 4), Mel; melanocytes
(N= 5), Fib; fibroblasts (N= 5), KC; keratinocytes (N= 5). N represents number of biologically independent samples. Source data are provided as a Source
Data file.
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and the C-type lectin CLEC14A56. Furthermore, our analysis
yielded proteins such as KANK3, DYSF, HSPA12B, MYCT1 that
have not been functionally unexplored in the context of human
endothelial biology (Fig. 6s, t).
We used Melan-A (MLANA) as a characteristic marker for
melanocytes (Fig. 6u, v, Supplementary Data 15), the major
cellular source of the UV protective pigment melanin49. The
resulting set grouped together members of the melanogenesis
pathway such as tyrosinase (TYR), dopachrome tautomerase
(DCT) and neural crest-derived cell markers S100 and Cellular
retinoic acid binding protein 1 (CRABP1) (Supplementary Fig 1).
However, the analysis also identified a SLC6 family transporter
(SLC6A17), proteins that are enriched in brain and neural crest-
derived cells but lack biological characterization in the skin. We
also identified several proteins with no known role in melanocyte
biology, including SYNGR1, CRYM, MTURN, MAPT, MAP2,
FBLL1 (Fig. 6w, x).
Taken together, the integration of FACS cell sorting, MS-based
quantitative proteomics, and protein marker based analyses of cell
type-specific characteristic sets revealed a large number of
proteins with unexplored roles in skin biology.
Discussion
The skin defines the interface of the human body with its external
surroundings. It has a variety of functions that are reflected in its
intricate cellular and mechanical structure. These functions are
carried out by proteins and yet, to date there has been no in-
depth, cell-type- and location-specific proteomic studies of this
organ. The high dynamic range (difference between most abun-
dant and least abundant proteins) of the skin proteome have long
presented an unsurmountable barrier to comprehensive quanti-
tative proteomic analyses. The presence of highly abundant
proteins, such as collagens in the dermis, make it difficult to
detect low abundance proteins. Additionally, many cell types are
present in low numbers and cannot be effectively characterized
with current levels of sensitivity.
In this study, we overcame these challenges and quantitatively
characterized the proteomic composition of healthy human skin.
We used a combination of curettage, skin dissection, FACS
sorting and primary cell culture to separate the skin into four
layers and nine cell types. We successfully generated a proteomic
atlas of 10,701 proteins, by far the largest collection of proteomic
data obtained to date from human skin. We expect that many
novel and unexpected insights will emerge from future analysis of
this data, given its comprehensive and multidimensionally
resolved nature.
We provide some initial illustrations of the types of insights
that our dataset can yield. For example, our structural protein
quantification revealed that just five of all the described keratins
in epidermis—KRT 1, 5, 10, 14, and 6A—accounted for 87% of
total keratin mass and 10% of total protein mass in epidermal
compartments, suggesting that low abundance keratins may have
non-structural roles (such as serving as alarmins)29. Likewise we
quantified 16 collagens in dermis and subcutis, including col-
lagens I, III, IV, and VI, which accounted for 96% of the total
collagen mass in the dermis. We also made the observation that
collagen XXI is expressed in human skin, which has not pre-
viously been described. Knowledge of the identity, quantity, and
spatial distribution of these key skin proteins will contribute to a
more holistic understanding of skin structure and function.
To characterize the proteins underlying the immune-protective
role of the skin, we quantified a large number of proteins with
pro-inflammatory- and antimicrobial activities, including che-
mokines, matrix metalloproteinases, S100 family members,
interleukins and other cytokines. These studies revealed that there
were surprisingly large quantitative and spatial differences in
protein expression in different layers of the skin. We also com-
prehensively cataloged the protein composition of cultured first
passage keratinocytes and fibroblasts to complement our skin
layer-based proteomic analyses. Lastly, we further captured the
complexity of the human skin proteome by separately analyzing
major constituent cell types, including melanocytes, endothelial
cells, macrophages, dendritic cells, mast cells, and dermal- and
epidermal T cells. Our analyses identified distinct proteomic
profiles in each cell type, indicating that unique group of protein
defines their differential biology. Strikingly, we identified proteins
in each cell type that have not been previously associated with
skin biology. We predict that further mining of this proteome
atlas will expand our fundamental insight into the biology of skin.
In summary, we describe a high-resolution comprehensive
proteomic analyses of healthy human skin, including the detailed
study of different skin layers and distinct cell types. It is our hope
that this atlas will serve as a rich resource for future analyses of
skin and immune cell function and serve as a foundation for the
study of proteomic alterations in skin disease. Future proteomic
analyses of skin disease such as psoriasis could open a door for
personalized medicine, identify previously unsuspected patholo-
gic mechanisms, and identify possible new targets for treatment.
This atlas could also serve as a rich resource for understanding
how single gene-based disorders, such as filaggrin deficiency,
affect the surrounding skin and contribute to clinically evident
disease. The high sensitivity of our approaches and the and
minimal required starting materials should enable in-depth pro-
teomics analyses of even small skin biopsies, perhaps enabling the
use of MS-based studies as diagnostic tools.
Methods
Ethics oversight. The study was carried out in agreement with the Danish and
Dutch law (Medical Research Involving Human Subjects Act), in accordance with
the guidelines of the Medical Ethics Review Committees of the involved institutes
and following the Declaration of Helsinki principles.
Discarded skin tissues from corrective surgery of the breast or abdomen were
anonymized prior to providing them to the authors of the paper, who were not
involved in the surgeries during which the tissues were collected. According to the
Danish and Dutch law, researchers are allowed to use discarded anonymous tissue
without patient consent.
Human peripheral blood was obtained from healthy adult volunteers
(independent from the skin donors) via a vene puncture after written informed
consent using an approved protocol by the Ethics Committee of the Capital Region
of Denmark (H-3-2014-123 version 1 from 30 07 2018) and complying with the
ethical regulations for work with human participants.
Tissue preparation. Discarded abdominal skin was obtained from cutaneous
surgeries and processed within an hour after surgery. Stratum corneum was cur-
etted carefully with an 8 mm curette and snap frozen in liquid nitrogen. Next,
stratum spinosum, stratum granulosum and stratum basale (together with
remaining traces of stratum corneum) were curetted and collected as one sample. A
4 mm punch biopsy was collected and divided in upper dermis and subcutis.
Visible fat was separated from the rest and snap frozen individually. After each
step, a punch biopsy was collected to ensure the histological accuracy (Supple-
mentary Fig. 1a–c). Two additional 4 mm biopsies were collected, one biopsy was
covered in Tissue-Tek O.C.T. Compound (Sakura, Cat. no. 4583) and snap frozen
and the second biopsy was stored in formaldehyde for 24 h and subsequently
paraffin embedded.
Skin biopsies from discarded tissue were incubated in 50 U/ml dispase (Sigma,
cat. no. 4942078001) at 4 °C overnight. Epidermis and dermis were separated with
forceps. Primary cultures of dermal fibroblasts were initiated by placing 3 mm
pieces of the dermal portions in 6-well plates in 3 ml DMEM/F12 fibroblast
medium (Corning/Mediatech, cat. no. 10-090-CV) containing 15% FCS (Sigma,
cat. no. F7524), 1% penicillin-streptomycin (Sigma, cat. no. 0781), 1% L-Glutamine
(Sigma, cat. no. G03202) and EGF (10 ng/mL) (Peprotech, cat. no. AF-100-15). The
skin pieces were removed when adherent fibroblasts were visible in the wells.
Epidermal strips were pelleted by spinning 250g, 5 min and resuspended in
prewarmed trypsin/EDTA (Sigma, cat. no. T3924) and incubated 5 min at 37 °C.
Trypsin was neutralized by FCS and cells were rinsed 3 times with RPMI (Corning/
Mediatech, Cat. no. 10-040-CV) containing 1% BSA (Sigma, cat. no. 05470) and
1% penicillin-streptomycin. Larger pieces were removed with forceps and
remaining cells were counted with trypan blue viability dye (Bio-Rad, cat. no.
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1450021) and plated in keratinocyte growth medium (Gibco/Life Technologies, cat.
no. 17005-042) including 1% penicillin–streptomycin in 8 cm plates. Cultures were
fed three times per week by careful aspiration of approximately half of the culture
medium and replacement with fresh medium.
Processing of skin and purification of skin resident immune cell subsets.
Residual human skin tissue was obtained from healthy donors (aged between 18
and 65 years) undergoing corrective surgery of the breast or abdomen. Within 2 h
after resection, sheets of 0.3–0.4 mm thickness were prepared with an electro-
dermatome and were treated overnight at 4 °C with 0.2% (wt/vol) dispase II
(Boehringer Mannheim, Mannheim, Germany) in PBS with 50 µg/ml gentamycin
(Sigma, St. Louis, MO). Epidermis and dermis were separated by forceps, and in
order to get fresh single-cell suspensions, the epidermis was fragmented by scissors
and incubated in 0.25% (wt/vol) trypsin in PBS for 30 min at 37 °C, while the
fragmented dermis was incubated in IMDM (Corning, cat. no. MT10016CV) with
0.4%(wt/vol) collagenase D (Sigma, cat. no. C0130-1G), 50 U/mL DNAse I (Sigma,
cat. no. D4263-1VL) and 0.5% (vol/vol) FCS for 2–3 h at 37 °C. After enzymatic
digestion, the cell suspensions were sieved through 70-µm cell strainers (Falcon) to
remove tissue debris, yielding single cells with a viability exceeding 97%. In order to
sort epidermal T cells and melanocytes by flow cytometry, the cell surface of freshly
prepared epidermal cells was labeled with the following anti-human protein anti-
bodies (dilution, clone, catalog number, manufacturer): FITC–conjugated CD1a
(1:100, HI149, 555806) and PE-conjugated HLA-DR (1:100, G46-6, 555812, both
BD Pharmingen), PE-CF594-conjugated CD3 (1:200,UCHT1, 562280) and APC-
Cy7-conjugated CD45 (1:200, 2D1, 348815, both BD Biosciences), APC-conjugated
CD94 (1:100, DX22, 305508, BioLegend), PE-Cy5.5-conjugated CD117 (1:100,
104D2D1, A66333, Beckman Coulter).
In order to sort CD4+ or CD8+ T-cells, dendritic cell subsets, macrophages,
mast cells and endothelial cells from freshly prepared dermal cell suspension the
following anti-human antibodies were used: APC-Cy7-conjugated CD45, PE-
CF594-conjugated CD3, PE-Cy5.5-conjugated CD117, PE-conjugated HLA-DR,
FITC-conjugated CD14 (1:100, MφP-9, 345784, BD Biosciences), FITC-conjugated
CD94 (1:100, HP-3D9, 555888, BD Pharmingen), BV421-conjugated FcεRIa
(1:100, AER-37, 334624, BioLegend), PE/Dazzle594-conjugated CD4 (1:200, OKT4,
317448, BioLegend), PE-Cy7-conjugated CD8 (1:100, RPA-T8, 557746, BD
Pharmingen), PE-conjugated CD11b (1:100, Bear1, PN IM2581, Immunotech),
APC-conjugated CD11c (1:100, S-HCL-3, 333144, BD Biosciences), BV605-
conjugated CD3 (1:100, OKT3, 317322, BioLegend), BV421-conjugated CD1a
(1:100, HI149, 300128, BioLegend), PE/Dazzle594-conjugated CD14 (1:200,
HCD14, 325634, BioLegend), PE-Cy7-conjugated CD3 (1:100, SK7, 344816,
BioLegend), FITC-conjugated CD31 (1:100, WM59, 303104, BioLegend), PE-Cy7-
conjugated CD34 (1:100, 581, 343516, BioLegend). Cells were sorted by FACSAria
cell-sorting equipment (BD Biosciences), using an 85-µm nozzle (Supplementary
Fig. 3). Sorted cells were washed 2 times with PBS, and finally, cell pellets were
immediately snap-frozen in liquid nitrogen and stored at −80 °C until further
processing.
Isolation of PBMCs. PBMCs were derived from healthy individuals (see “Ethics
oversight” above) and separated by density gradient centrifugation over Lym-
phoprep (Nycomed-Pharmacia, cat. no. 1114547, Oslo, Norway), collected at the
interface and washed twice in PBS.
Sample preparation for mass spectrometry. Samples of skin layers were sus-
pended in 200 µl, 50 mM Tris-HCl pH8 and individually mixed using an ultra-
Turrax blender (T 10 basic ultra, IKA, Staufen, Germany) for 30 s x 8 while kept on
ice. 200 µL lysis buffer 2,2,2-trifluoroethanol (TFE) (final concentration 50% [v/v]
as well as 5 mM DTT) was added, and the samples were heated for 10 min in the
thermomixer. The protocol was slightly modified for the cultivated cells and FACS-
sorted cells where there was no need for tissue homogenization. Lysis buffer
(containing 20% TFE/ 39,5 mM TRIS HCL/ 5 mM DTT) was added directly to the
cell pellets and vortexed for 30 s, and the samples were heated for 10 min in the
thermomixer.
The samples were placed shortly on ice and subsequently sonicated using a
biorupter 15 cycles of 30 s. To prevent the disulfide-bonds to restore, IAA were
added to a final concentration of 25 mM. The samples were left in dark for 20 min
and then dried using vaccum concentrator (#5424 R, Eppendorf, VWR, Søborg,
DK) for 30 min at 30 ̊C. 200 µL digestion buffer (50 mM Tris-HCl, pH 8) was
added including Lys-C and trypsin (dependent on the cell number or tissue
amount to an estimated enzyme to protein ratio of 1:50), and left overnight in
thermomixer for digestion (37 °C, 1300 rpm) to be digested. The following day
peptides were acidified 1% trifluoroacetic acid (TFA) to stop digestion and allow
for binding to SDB-RPS StageTips. The samples were loaded on 4 layers SDS-RPS
material Stage-Tip plugs, and centrifuged at 500 g for 10 min. The samples were
washed twice with 0,2% TFA (200 µL), and lastly eluted with 60 µL elution buffer
(80% acetonitrile/1% ammonia [v/v]) into a MS-plate (#AB-1300, Thermo
Scientific, Life Technologies Europe, Roskilde, DK) and dried using a vaccum
concentrator (45 min at 45 ̊C). Peptides were resuspended in 8 µL loading buffer,
2% acetonitrile in 0.1% TFA and peptide concentration was measured using the
Nanodrop®. In addition to the sample processing of each individual sample, we
created matching libraries of pooled samples from the same sample type for high-
pH reversed-phase fractionation. About 15–25 µg of peptides were further
fractionated into 8 or 16 fractions depending on peptide yield. Supplementary
Data 18 provides an overview of the number of fractions in each sample. 500 ng of
each unfractionated and fractionated samples was used for subsequent LC-MS
analysis.
LC-MS/MS analysis. Nanoflow LC-MS/MS analysis of tryptic peptides was con-
ducted on a quadrupole Orbitrap mass spectrometer (Q Exactive HF-X, Thermo
Fisher Scientific, Bremen, Germany)15 coupled to an EASY nLC 1200 ultra-high-
pressure system (Thermo Fisher Scientific) via a nano-electrospray ion source. 500
ng of peptides were loaded on a 50-cm HPLC-column (75 μm inner diameter, New
Objective, Woburn, MA, USA; in-house packed using ReproSil-Pur C18-AQ 1.9-
µm silica beads; Dr Maisch GmbH, Ammerbuch, Germany). Peptides were sepa-
rated using a linear gradient from 2 to 20% B in 55 min and stepped up to 40% in
40 min followed by a 5 min wash at 98% B at 350 nl per minute where solvent A
was 0.1% formic acid in water and solvent B was 80% ACN and 0.1% formic acid in
water. The total duration of the run was 100 min. Column temperature was kept at
60 °C using an in-house-developed oven.
For spectral library generation, samples were fractionated using a high pH
reversed-phase fractionator as previously described and measured in DDA mode20.
Briefly, the mass spectrometer was operated in “top-15” data-dependent mode,
collecting MS spectra in the Orbitrap mass analyzer (60,000 resolution, 300–1650
m/z range) with an automatic gain control (AGC) target of 3E6 and a maximum
ion injection time of 25 ms. The most intense ions from the full scan were isolated
with an isolation width of 1.4m/z. Following higher-energy collisional dissociation
(HCD) with a normalized collision energy (NCE) of 27, MS/MS spectra were
collected in the Orbitrap (15,000 resolution) with an AGC target of 1E5 and a
maximum ion injection time of 28 ms. Precursor dynamic exclusion was enabled
with a duration of 30 s.
For DIA, the acquisition method consisted of one MS1 scan (350 or 300 to
1650m/z, resolution 60,000 or 120,000, maximum injection time 60 ms, AGC
target 3E6) and 32 segments at varying isolation windows from 14,4m/z to 562.8
m/z (resolution 30,000, maximum injection time 54 ms, AGC target 3E6). Stepped
normalized collision energy was 25, 27.5 and 30. The default charge state for MS2
was set to 2.
MS data analysis. DDA raw files were processed in the MaxQuant environment
(1.6.3.4)57. The integrated Andromeda search engine was used for peptide and
protein identification at an FDR of less than 1%. The human UniProtKB database
(October 2017) was used as forward database and the automatically generated
reverse database for the decoy search. “Trypsin” was set as the enzyme specificity.
Search criteria included carbamidomethylation of cysteine as a fixed modification,
oxidation of methionine, acetyl (protein N-terminus) as variable modifications. We
required a minimum of 7 amino acids for peptide identification. Proteins that
could not be discriminated by unique peptides were assigned to the same protein
group. The “match-between-runs” (MBR) option was enabled. MBR was restricted
to samples of the same type (skin primary cells, skin tissue layers). Label free
quantification was performed using the iBAQ approach58. Proteins, which were
found as reverse hits or only identified by site-modification, were filtered out. DIA
raw files were analyzed using Spectronaut Pulsar X software (Biognosys, version
12.0.20491.17) and default settings for targeted DIA analysis with the “mutated” as
decoy method. Data export was filtered by “No Decoy” and “Quantification Data
Filtering” for peptide and protein quantifications. Prior to data analysis, protein
quantification values were median normalized.
Statistical analysis. All statistical and bioinformatic analyses were performed
using Perseus (version 1.6.2.3)59, the R framework (version 3.6.0, https://www.r-
project.org/) and CKG’s Analytics core (version 1.0b)60. Heatmaps were generated
using the open source tool Morpheus (https://software.broadinstitute.org/
morpheus). Missing values (those displayed as 0 or “NaN” in the MaxQuant
output) were imputed using the MinProb approach (random draws from a
Gaussian distribution; width = 0.3 and downshift = 1.8).
Immunohistochemical analysis. Immunohistochemical studies were performed
on formalin fixed and paraffin embedded sections using the antibodies outlined in
Supplementary Data 16. Anti-human K1 and K14 were used for double immuno-
labeling experiment and staining, both single and double, were performed on the
fully automated instrument Omnis (Dako, Glostrup, Denmark). Between all
incubation steps, slides were rinsed in wash buffer. Slides were subjected to
dewaxing and subsequently to antigen retrieval using either Target Retrieval
Solution (TRS), High pH (Agilent/Dako, Glostrup, Denmark Cat. no GV800) at
97 °C (24 min) or TRS Low pH (Agilent/Dako, Cat. no GV805) at 97 °C (20 min)
followed by digestion in pepsin solution (ZytoVision GmbH, Bremerhaven, Ger-
many, cat.no. ES-0002-50) at 32 °C (12 min). After pre-treatment, slides were
incubated with the primary antibodies CD31 clone JC/70A (Ready-to-use), CD163
clone MRQ-26 (1:100), MART1 clone EP43 (1:100), CK10 clone DE-K10 (1:50),
CK14 clone SP53 and polyclonal Collagen III (1:500) at 32 °C (30 min). The
reactions were visualized using EnVision™ FLEX /HRP/DAB Detection Reagent
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(Agilent/Dako, Cat. no. GV800+GV809/821) following the manufacturer’s
instructions. Intensity of the reactions were amplified using either EnVision™
FLEX+Mouse (LINKER) or EnVision™ FLEX+ Rabbit (LINKER) depending on
the host of the primary antibody. For the polyclonal antibody IL1-β (1:50), reac-
tions were detected using Rabbit-anti-Goat/HRP (Agilent/Dako, Cat. no. P0449)
diluted 1:100 in wash buffer and incubated at 32 °C (30 min). Visualization was
completed using the DAB substrate reagent from above mentioned Kit (Agilent/
Dako, Cat. no. GV800+GV809/821). Information about the immunohistochem-
ical stainings obtained with courtesy from the Human Protein Atlas61 can be found
in Supplementary Data 17.
Double immuno-labeling technique. Dewaxing and pre-treatment was done as
described above. Sequential double immuno-staining was performed using anti-
human K10 clone DE-K10 (1:50) in combination with anti-human CD14 clone
SP53 (1:200). In the first sequence, slides were incubated with K10 for 30 min
(32 °C) and reactions were visualized using EnVision™ FLEX /HRP/DAB Detection
Reagent (Agilent/Dako, Cat. no. GV800+ 821) following the recommendation of
the manufacturer. After the visualization with DAB, slides were subsequently
incubated with K14 for 30 min (32 °C). The reactions for K14 were detected with
EnVision™ FLEX /HRP Detection Reagent (Agilent/Dako, Cat. no. GV800+ 821)
and visualized with Magenta Substrate chromogen system (Agilent/Dako, Cat. no.
GV925) following instructions given by the vendor. All slides, both single and
double stained, were counterstained with Haematoxylin and mounted with Pertex.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The proteomic datasets generated in the current study have been deposited to the
ProteomeXchange Consortium via the PRIDE partner repository with the dataset
identifier “PXD019909”.62 Proteomics data included in this manuscript can be queried at
https://skin.science/. Source data are provided with this paper.
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